Iohexol Imax

Iohexol, the active ingredient in Iohexol Imax, is an iodinated contrast media presented as a sterile solution for injection for intra‑arterial and intravenous use. It enhances X‑ray attenuation, allowing clearer visualization of vascular and tissue structures during computed tomography, angiography and other radiographic examinations in adult and pediatric patients.

GNH USA supplies Iohexol Imax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies, clinics and diagnostic imaging centres worldwide.

Iohexol is used as an iodinated contrast agent to improve radiographic visualization in several diagnostic imaging procedures. - Computed Tomography (CT) imaging: provides enhanced contrast to delineate organs, vessels and lesions. - Angiography: improves visualization of arterial and venous structures during catheter‑based studies. - Conventional X‑ray examinations: supplies contrast for urography, arthrography and other radiographic studies requiring tissue differentiation.

Adverse reactions to Iohexol Imax may range from mild to severe and are reported in clinical practice.

Common Side Effects: - Warmth or flushing: transient sensation during injection. - Nausea: mild gastrointestinal upset. - Metallic taste: brief alteration in oral sensation.

Serious or Rare Side Effects: - Hypersensitivity reaction: urticaria, bronchospasm or anaphylaxis. - Renal impairment: contrast‑induced nephropathy, especially in patients with pre‑existing kidney disease. - Cardiovascular collapse: severe hypotension or arrhythmia.

When using Iohexol Imax, clinicians should observe several precautions to minimize risk and ensure optimal imaging outcomes. - Assess renal function: evaluate serum creatinine and eGFR before administration. - Review allergy history: identify prior reactions to iodinated contrast or related agents. - Hydration status: ensure adequate patient hydration to reduce nephrotoxicity. - Concomitant nephrotoxic drugs: avoid or adjust dosage of NSAIDs, aminoglycosides, or other renal‑impairing medications. - Pregnancy and lactation: use only if benefits outweigh potential risks, as safety data are limited. - Store at ambient temperature: keep in original container, protect from light and moisture, do not freeze.

Iohexol Imax may interact with other agents, affecting safety or diagnostic quality.

Major Interactions (Avoid): - Metformin: risk of lactic acidosis in renal impairment; discontinue before and after contrast as per guidelines. - Iodine‑containing medications: may increase total iodine load, potentially affecting thyroid function.

Moderate Interactions (Monitor Closely): - Diuretics: may exacerbate volume depletion and renal risk; monitor fluid status. - ACE inhibitors/ARBs: can potentiate contrast‑induced nephropathy; consider temporary suspension. - NSAIDs: increase risk of renal dysfunction; assess necessity.